- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 14, 2024 | 281.95M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $14.96K |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $3.81M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $2.41M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $4.69M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $3.48M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $1.82M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $656.16K |
| Total Assets | Q3 2024 · Sep 30, 2024 | $2.76M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $4.28M |
| Total Assets restated | Q3 2024 · Sep 30, 2023 | $5.69M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 265.52M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 260.85M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $1.5K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$2.95M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $1.56M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $1.57M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $2.17M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $314.45K |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.00 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $767.71K |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $2.71M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$174.92K |
| Net Income | Q3 2024 · Sep 30, 2023 | $273.56K |
| Net Income | Q3 2024 · Jun 30, 2023 | −$1M |
| Net Income | Q3 2024 · Mar 31, 2023 | $1.45M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.18M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$3.04M |